LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article: Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of Yersinia pestis for a Rapid Plague Outbreak Response

    Moses, Sarit / Aftalion, Moshe / Mamroud, Emanuelle / Rotem, Shahar / Steinberger-Levy, Ida

    Microorganisms. 2021 June 11, v. 9, no. 6

    2021  

    Abstract: Pneumonic plague is a lethal infectious disease caused by Yersinia pestis, a Tier-1 biothreat agent. Antibiotic treatment can save infected patients; however, therapy should begin within 24 h of symptom onset. As some Y. pestis strains showed an ... ...

    Abstract Pneumonic plague is a lethal infectious disease caused by Yersinia pestis, a Tier-1 biothreat agent. Antibiotic treatment can save infected patients; however, therapy should begin within 24 h of symptom onset. As some Y. pestis strains showed an antibiotic resistance phenotype, an antibiotic susceptibility test (AST) must be performed. Performing the Clinical and Laboratory Standards Institute (CLSI)-recommended standard process, which includes bacterial isolation, enumeration and microdilution testing, lasts several days. Thus, rapid AST must be developed. As previously published, the Y. pestis-specific reporter phage ϕA1122::luxAB can serve for rapid identification and AST (ID-AST). Herein, we demonstrate the ability to use ϕA1122::luxAB to determine minimal inhibitory concentration (MIC) values and antibiotic susceptibility categories for various Y. pestis therapeutic antibiotics. We confirmed the assay by testing several nonvirulent Y. pestis isolates with reduced susceptibility to doxycycline or ciprofloxacin. Moreover, the assay can be performed directly on positive human blood cultures. Furthermore, as Y. pestis may naturally or deliberately be spread in the environment, we demonstrate the compatibility of this direct method for this scenario. This direct phage-based ID-AST shortens the time needed for standard AST to less than a day, enabling rapid and correct treatment, which may also prevent the spread of the disease.
    Keywords Yersinia pestis ; antibiotic resistance ; bacteriophages ; blood ; ciprofloxacin ; disease transmission ; doxycycline ; humans ; minimum inhibitory concentration ; phenotype ; plague ; therapeutics
    Language English
    Dates of publication 2021-0611
    Publishing place Multidisciplinary Digital Publishing Institute
    Document type Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms9061278
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  2. Article: Reporter-Phage-Based Detection and Antibiotic Susceptibility Testing of

    Moses, Sarit / Aftalion, Moshe / Mamroud, Emanuelle / Rotem, Shahar / Steinberger-Levy, Ida

    Microorganisms

    2021  Volume 9, Issue 6

    Abstract: Pneumonic plague is a lethal infectious disease caused ... ...

    Abstract Pneumonic plague is a lethal infectious disease caused by
    Language English
    Publishing date 2021-06-11
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2720891-6
    ISSN 2076-2607
    ISSN 2076-2607
    DOI 10.3390/microorganisms9061278
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Characterization of

    Moses, Sarit / Vagima, Yaron / Tidhar, Avital / Aftalion, Moshe / Mamroud, Emanuelle / Rotem, Shahar / Steinberger-Levy, Ida

    Viruses

    2021  Volume 13, Issue 1

    Abstract: The global increase in multidrug-resistant (MDR) pathogenic bacteria has led to growing interest in bacteriophage ("phage") therapy. Therapeutic phages are usually selected based on their ability to infect and lyse target bacteria, using in vitro assays. ...

    Abstract The global increase in multidrug-resistant (MDR) pathogenic bacteria has led to growing interest in bacteriophage ("phage") therapy. Therapeutic phages are usually selected based on their ability to infect and lyse target bacteria, using in vitro assays. In these assays, phage infection is determined using target bacteria grown in standard commercial rich media, while evaluation of the actual therapeutic activity requires the presence of human blood. In the present work, we characterized the ability of two different
    MeSH term(s) Bacteriolysis ; Bacteriophages/physiology ; Humans ; Phage Therapy ; Plague/therapy ; Plague/virology ; Precision Medicine ; Viral Load ; Yersinia pestis/virology
    Language English
    Publishing date 2021-01-11
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v13010089
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Phage Therapy Potentiates Second-Line Antibiotic Treatment against Pneumonic Plague.

    Vagima, Yaron / Gur, David / Aftalion, Moshe / Moses, Sarit / Levy, Yinon / Makovitzki, Arik / Holtzman, Tzvi / Oren, Ziv / Segula, Yaniv / Fatelevich, Ella / Tidhar, Avital / Zauberman, Ayelet / Rotem, Shahar / Mamroud, Emanuelle / Steinberger-Levy, Ida

    Viruses

    2022  Volume 14, Issue 4

    Abstract: Plague pandemics and outbreaks have killed millions of people during the history of humankind. The disease, caused by the ... ...

    Abstract Plague pandemics and outbreaks have killed millions of people during the history of humankind. The disease, caused by the bacteria
    MeSH term(s) Animals ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Bacteriophages ; Disease Models, Animal ; Humans ; Mice ; Phage Therapy ; Plague/drug therapy ; Yersinia pestis
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-03-26
    Publishing country Switzerland
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14040688
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top